Johnson Karen Marie
SEC CIK 1892819 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| STLN | Starling Oncology, Inc. | Dir | 319.4K | $37.7K | — | 8 | 2022-03-21 | 2026-07-27 |
Most active insiders at STLN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chernett Jorey | 10% | $2.69M | — |
| 2 | Hively Brad | Dir | — | $2.00M |
| 3 | Kaushal Mohit | Dir | — | $335.1K |
| 4 | Podnos Yale | Chief Medical Off | — | $276.4K |
| 5 | Pacala Mark L | Dir | — | $200.0K |
| 6 | Carter Robert Ross | CFO | — | $879.32 |
| 7 | England Kristin | Chief Administrative Off | — | — |
| 8 | Langsam Jeffrey | Chief Clinical Off | — | — |
| 9 | Ling Gabriel | Dir | — | — |
| 10 | TOI M, LLC | Dir | — | — |
| 11 | Johnson Karen Marie | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-29 18:46 | 2026-07-27 | STLN | Starling Oncology, Inc. | Johnson Karen Marie | Dir | A - Grant | $0.00 | +31.1K | 319.4K | +11% | $0 | |
| M | 2025-11-24 | 2025-11-20 | STLN | Starling Oncology, Inc. | Johnson Karen Marie | Dir | A - Grant | $0.00 | +84.9K | 251.2K | +51% | $0 |
| D | 2025-03-28 | 2025-03-26 | STLN | Starling Oncology, Inc. | Johnson Karen Marie | Dir | P - Purchase | $1.04 | +36.2K | 203.4K | +22% | +$37.7K |
| 2024-11-25 | 2024-11-22 | STLN | Starling Oncology, Inc. | Johnson Karen Marie | Dir | A - Grant | $0.00 | +52.0K | 167.2K | +45% | $0 | |
| 2023-12-28 | 2023-12-26 | STLN | Starling Oncology, Inc. | Johnson Karen Marie | Dir | A - Grant | $0.00 | +52.0K | 115.2K | +82% | $0 | |
| 2023-03-21 | 2023-03-17 | STLN | Starling Oncology, Inc. | Johnson Karen Marie | Dir | A - Grant | $0.00 | +19.7K | 63.2K | +45% | $0 | |
| 2022-11-21 | 2022-11-17 | STLN | Starling Oncology, Inc. | Johnson Karen Marie | Dir | A - Grant | $0.00 | +22.7K | 43.5K | +109% | $0 | |
| M | 2022-03-23 | 2022-03-21 | STLN | Starling Oncology, Inc. | Johnson Karen Marie | Dir | A - Grant | $0.00 | +20.8K | 20.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations